p 2024

Harnessing the EphA2 blockade in glioblastoma

JURÁŇ, Vilém; Václav VYBÍHAL; Marek SOVA; Martin SMRČKA; Tomáš KAZDA et. al.

Basic information

Original name

Harnessing the EphA2 blockade in glioblastoma

Authors

JURÁŇ, Vilém (203 Czech Republic, belonging to the institution); Václav VYBÍHAL (203 Czech Republic, belonging to the institution); Marek SOVA (203 Czech Republic, belonging to the institution); Martin SMRČKA (203 Czech Republic, belonging to the institution); Tomáš KAZDA (203 Czech Republic, belonging to the institution); Martin PISKÁČEK (203 Czech Republic, belonging to the institution) and Andrea KNIGHT (203 Czech Republic, belonging to the institution)

Edition

4th congress on the Eph-ephrin system, Parma, Italy, May 16-17, 2024, 2024

Other information

Language

English

Type of outcome

Requested lectures

Field of Study

30212 Surgery

Country of publisher

Italy

Confidentiality degree

is not subject to a state or trade secret

RIV identification code

RIV/00216224:14110/24:00139938

Organization unit

Faculty of Medicine

Keywords in English

glioblastoma; EphA2 blockade

Tags

International impact
Changed: 20/8/2024 08:23, Mgr. Tereza Miškechová

Abstract

In the original language

Harnessing the EphA2 blockade in glioblastoma - conference abstract.

Links

NV19-05-00410, research and development project
Name: Úloha cytotoxických gamma-delta T buněk na terapeutické rezistenci a recidivě Glioblastoma Multiforme
Investor: Ministry of Health of the CR